Publikationen Prof. Dr. med. Schmelz ( PDF , 490 kB)

Publikationsverzeichnis: Prof. Dr. med. Hans Ulrich Schmelz 

1. Peer reviewed Originalarbeiten 

(Erstautor oder korrespondierender Autor) 

14. Testis cancer cells have a genetic determination for a high 

sensitivity to apoptosis inducing stimuli. 

Schmelz HU, Port M, Stockinger M, Ruf C, Martinscheck A, Sparwasser C, Weidner W, 

Abend M. 

Urol Oncol. 2010 28: 49-58 

13. A gene signature of primary tumor identifies metastasized seminoma. 

Port M, Wang Y, Schmelz HU, Pottek T, Meineke V, Ruf C, Abend M 

Urol Oncol. 2009 Nov 26. [Epub ahead of print] PubMed PMID: 19945308. 

12. Value of targeted treatment for testicular cancer: from molecular approaches to 

clinical possibilities. 

Martinschek A, Ruf CG, Sparwasser C, Schmelz HU. 

Urologe 2008, 47: 1328-33 

11. Correcting false gene expression measurements from degraded RNA using RTQ-PCR. 

Port M, Schmelz HU, Stassen T, Mueller K, Stockinger M, Obermair R, Abend M. 

Diagn Mol Pathol 2007, 16: 38-49 

10. Metanephric adenoma of the kidney: case report and 

review of the literature 

Schmelz HU, Danz B, Schwerer M, Hauck EW, Weidner W, Sparwasser C 

Int Urol Nephrol 2005; 37: 213-217 

1


9. Apoptosis – key effector mechanism of lymphocyte action in human testicular 

carcinoma 

Schmelz HU, Port M, Hauck E, Schwerer MJ, Weidner W, Sparwasser C, Abend M 

BJU Int 2005, 96: 158-163 

8. Apoptosis in non-tumorous adult human testis tissue: comparison of so called 

"normal" testis tissues 

Schmelz HU, Meiswinkel J, Port M, Hauck E, Schwerer MJ, Weidner W, Sparwasser C, 

Abend M 

Urol Int 2005; 74: 349-354 

7. Gene expression profiling in seminoma and nonseminoma 

Port M, Schmelz HU, Sparwasser C, Albers P, Pottek T, Abend M 

J Clin Oncol 2005, 23: 58-69 

6. Comparative Analysis of Different Apoptosis Detection Methods in Human 

Testicular Cancer 

Schmelz HU, Abend M, Port M, Schwerer MJ, Hauck EW, Weidner W, Sparwasser C 

Urol Res 2004, 32: 332-337 

5. Significance of apoptosis in metastasizing testis tumors 

Abend M, Port M, Schmelz HU, Kraft K, Sparwasser C 

Urol Res 2004, 32: 28-35 

4. Fas/Fas ligand system and apoptosis induction in testicular carcinoma 

Schmelz HU, Abend M, Kraft K, Hauck EW, Weidner W, 

Van Beuningen D, Sparwasser C 

Cancer 2002, 95: 73-81. 

2


3. Graduate education in Germany. Path out of the dead end. 

Simon J, Kübler H, Necknig U, Schmelz HU. 

Urologe 2002: 174-6. 

2. Modified approach for apoptosis detection reveals changes in apoptotic 

processes in the seminoma associated tissue 

Abend M, Schmelz HU, Kraft K, Van Beuningen D, 

Sparwasser C 

Apoptosis 1999, 4: 283-290 

1. Apoptosis in human embryonal cell carcinoma: preliminary results 

Schmelz HU, Abend M, Kraft K, Van Beuningen D, Pust RA, Sparwasser C 

Urol Res 1999, 27: 368-375 

3


2. Peer reviewed Originalarbeiten (Koautor) 

Predicting metastasized seminoma using gene expression. 

Ruf CG, Linbecker M, Port M, Riecke A, Schmelz HU, Wagner W, Meineke V, Abend M. 

BJU Int. 2012 Jul;110 Epub 2012 Jan 13. 

A gene signature of primary tumor identifies metastasized seminoma. 

Port M, Wang Y, Schmelz HU, Pottek T, Meineke V, Ruf C, Abend M. 

Urol Oncol. 2011 Nov-Dec;29(6):764-73. Epub 2009 Nov 27. 

Topical treatment of erectile dysfunction with prostaglandin E₁ ethyl ester. 

Schanz S, Hauck EW, Schmelz HU, Weidner W, Fierlbeck G. 

J Dtsch Dermatol Ges. 2009 Dec;7(12):1055-9. 

16. III trial comparing retroperitoneal lymph node dissection with one course of bleomycin 

and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I 

Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German 

Testicular Cancer Study Group 

Albers P, Siener R, Krege S, Schmelz HU, Dieckmann KP, Heidenreich A, Kwasny, P, Pechoel M, Lehmann J, 

Kliesch S, Köhrmann KU, Fimmers R, Weissbach L, Loy V, Wittekind C, Hartmann M; German Testicular 

Cancer Study Group. 

J Clin Oncol 2008, 26: 2966-72 

15. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A 

report of the Second Meeting of the European Germ Cell Cancer Consensus Group 

(EGCCCG): Part II 

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin-Ståhl 

E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, de Wit R, 

Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, Garcia Del Muro X, Gauler 

T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, Hoeltl W, Horwich A, 

Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, Kollmannsberger C, 

Kuczyk M, Laguna P, Leiva Galvis O, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, Nicolai N, Oliver T, Ondrus 

D, Oosterhof GO, Paz Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti G, Salvioni R, Scheiderbauer J, 

Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, Skakkebaek NE, Sohaib A, Tjulandin S, 

Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, von der Maase H. 

Eur Urol 2008: 53: 497-513 

4


14. European Consensus Conference on Diagnosis and Treatment of Germ Cell Cancer: A 

report of the Second Meeting of the European Germ Cell Cancer Consensus Group 

(EGCCCG): Part I 

Krege S, Beyer J, Souchon R, Albers P, Albrecht W, Algaba F, Bamberg M, Bodrogi I, Bokemeyer C, Cavallin- 

Ståhl E, Classen J, Clemm C, Cohn-Cedermark G, Culine S, Daugaard G, De Mulder PH, De Santis M, de Wit M, 

de Wit R, Derigs HG, Dieckmann KP, Dieing A, Droz JP, Fenner M, Fizazi K, Flechon A, Fosså SD, Garcia Del 

Muro X, Gauler T, Geczi L, Gerl A, Germa-Lluch JR, Gillessen S, Hartmann JT, Hartmann M, Heidenreich A, 

Hoeltl W, Horwich A, Huddart R, Jewett M, Joffe J, Jones WG, Kisbenedek L, Klepp O, Kliesch S, Koehrmann KU, 

Kollmannsberger C, Kuczyk M, Laguna P, Leiva Galvis O, Loy V, Mason MD, Mead GM, Mueller R, Nichols C, 

Nicolai N, Oliver T, Ondrus D, Oosterhof GO, Paz Ares L, Pizzocaro G, Pont J, Pottek T, Powles T, Rick O, Rosti 

G, Salvioni R, Scheiderbauer J, Schmelz HU, Schmidberger H, Schmoll HJ, Schrader M, Sedlmayer F, 

Skakkebaek NE, Sohaib A, Tjulandin S, Warde P, Weinknecht S, Weissbach L, Wittekind C, Winter E, Wood L, 

von der Maase H. 

Eur Urol 2008: 53: 478-496 

13. Sclerosing Sertoli cell tumor of the testits: a rare tumor. Case report and review of the 

literature on the subtypes of Sertoli-cell tumor 

Werther M, Schmelz HU, Schwerer M, Sparwasser C 

Urologe A 2007; 46: 1551-1556 

12. A critical analysis of nonsurgical treatment of Peyronie’s disease 

Hauck EW, Diemer T, Schmelz HU, Weidner W 

Eur Urol 2006, 49: 987-997 

11. Testicular microlithiasis and testicular carcinoma: bilateral calcifications go with 

increased CIS risk 

Leinmüller L, Schmelz HU, Weißbach L 

Aktuelle Urologie, 2004, 35: 367-369 

5


10. Extracorporeal shock wave therapy for Peyronie's disease: exploratory meta-analysis of 

clinical trials 

Hauck EW, Mueller UO, Bschleipfer T, Schmelz HU, Diemer T, Weidner W 

J Urol 2004, 171: 740-745 

9. Questionable efficacy of extracorporeal shock wave therapy for Peyronie’s disease: 

results of a prospective approach 

Hauck EW, Hauptmann A, Bschleipfer T, Schmelz HU, Altinkilic BM, Weidner W 

J Urol 2004, 171: 296-299 

8. Giant multilocular cystadenoma of the prostate: a rare differential diagnosis of benign 

prostatic hyperplasia 

Hauck EW, Battmann A, Schmelz HU, Diemer T, Miller J, Weidner W, Knoblauch B 

Urol Int 2004, 73: 365-369 

7. Diagnostic value of magnetic resonance imaging in Peyronie's disease - a comparison 

both with palpation and ultrasound in the evaluation of plaque formation 

Hauck EW, Hackstein N, Vosshenrich R, Diemer T, Schmelz HU, Bschleipfer T, Schroeder- 

Printzen I, Weidner W 

Eur Urol 2003, 43: 293-299; discussion 299-300. 

6. Imaging Studies in the diagnosis of urogenital trauma 

Herbst A, Schmelz HU, Sparwasser C 

Urol Int 2003, 71: 341-349 

6


5. Epitheloid sarcoma of the penis – a rare differential diagnosis of Peyronie`s 

disease 

Hauck EW, Schmelz HU, Diemer T, Hackstein N, Fenchel K, Weidner W, Knoblauch B 

Int J Impot Res 2003, 15: 378-382 

4. Prospective analysis of single nucleotide polymorphisms of the transforming 

growth factor ß-1gene in peyronie’s disease 

Hauck EW, Hauptmann A, Schmelz HU, Bein G, Weidner W, Hackstein H 

J Urol 2003, 169: 369-372 

3. Role of intracellular Ca 2+ stores in smooth muscle of human penile erectile tissue 

Sparwasser C, Schmelz HU, Drescher P, Eckert R, Madsen PO 

Urol Res 1998, 26: 189-193 

2. Intercomparison of apoptosis morphology with active DNA cleavage on single 

cells in vitro and on testis tumors 

Abend M, Schmelz HU, Kraft K, Rhein AP, Van Beuningen D, Sparwasser C 

J Pathol 1998, 185: 419-426 

1. Pneumothoraxrezidiv nach chirurgischer Resektionsbehandlung 

Becker HP, Danz B, Schmelz HU, Radomsky J, Bähren W, Gerngroß H 

Der Chirurg 1997, 68: 255-258 

7


3. Buchbeiträge 

Radiologische Untersuchungen 

Wiedmann M, Schmelz HU 

In: Krause/Weidner/Sperling/Diemer: 

Andrologie – Krankheiten der männlichen Geschlechtsorgane, 

4. Auflage; Thieme Verlag 2011, Stuttgart, New York 

Krankheiten des Hodens; Tumoren, Hodentumoren 

Ruf C, Schmelz HU 

In: Krause/Weidner/Sperling/Diemer: 

Andrologie – Krankheiten der männlichen Geschlechtsorgane, 

4. Auflage; Thieme Verlag 2011, Stuttgart, New York, pp 275- 

284 

Keimzelltumore 

In: Schmelz/Sparwasser/Weidner: Facharztwissen Urologie 

Springer Verlag, 2010, Heidelberg, Berlin, New York 

Januar 2010, pp 377-418 

Keimzelltumore 

In: Schmelz/Sparwasser/Weidner: Facharztwissen Urologie 

Springer Verlag, 2006, Heidelberg, Berlin, New York 

Januar 2006, pp 258-300 

Conservative Treatment of Peyronie’s disease 

Hauck EW, Schmelz HU, Bschleipfer T, Weidner W 

In: Lahme S (ed) Peyronie's Disease. Uni-med Verlag, 

Bremen, London, Boston, 2005 

8


Hodentumor und sonstige testikuläre Erkrankungen 

In: Schill/Weidner/Bretzel: Männer Medizin 

Urban & Fischer Verlag, 2004 München, pp 453-464 

Geschichte der Urologie 

In: Schmelz/Leyh: Urologie, 1000 Kommentierte 

Prüfungsfragen 

Thieme Verlag, 2004 Stuttgart, New York, pp 1-4 

Hodentumore 




Maligne Erkrankungen des Penis 




9

Publikationen Prof. Dr. med. Schmelz ( PDF , 490 kB)

You also want an ePaper? Increase the reach of your titles

Delete template?

Save as template?